Small Cell Carcinoma: a Rare Subtype of Thyroid Cancer with Unanticipated Prognosis

Abstract

The prognosis of small cell thyroid carcinoma (SCTC) in a large cohort has not been well reported in the literature. In this study, we analyzed the mortality of SCTC, in comparison to medullary thyroid cancer (MTC) and anaplastic thyroid cancer (ATC), based on the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, to determine the prognosis of SCTC. Information regarding patients with a diagnosis of MTC, ATC, or SCTC, between 2004 and 2013, was acquired from the SEER database. Patient survival curves were assessed by Cox proportional hazards regression analyses, Kaplan-Meier analyses, and log-rank tests. In a Kaplan-Meier analysis of the entire cohort of thyroid cancer patients, cancer-specific survival declined sharply for patients with SCTC, but it declined more modestly for patients with MTC. The cancer-specific survival was not significantly different between SCTC and ATC. Unadjusted Cox regression analysis showed that SCTC had a higher cancer-specific mortality than MTC but a similar prognosis as ATC. SCTC showed a higher cancer-specific mortality than MTC and ATC after adjustments for various confounding factors. SCTC was found to have a more highly lethal clinical course than MTC and had a similar death rate to ATC. Therefore, we recommend that aggressive, radical treatment like surgery or radiation should be performed for these patients.

Keywords

small cell carcinoma / medullary thyroid cancer / anaplastic thyroid cancer

References

[1] DaviesL, WelchHG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA, 2006, 295(18): 2164-2167

[2] MaoY, XingM. Recent incidences and differential trends of thyroid cancer in the USA. Endocr Relat Cancer, 2016, 23(4): 313-322

[3] LiuC, WangS, ZengW, et al.. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis. Sci Rep, 2017, 7(1): 1846

[4] HuangXQ, HeWS, ZhangHQ, et al.. Relationship between expression of vascular endothelial growth factor and cervical lymph node metastasis in papillary thyroid cancer: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci, 2017, 37(5): 661-666

[5] AuJK, AlonsoJ, KuanEC, et al.. Primary squamous cell carcinoma of the thyroid: A population-based analysis. Otolaryngol Head Neck Surg, 2017, 157(1): 25-29

[6] ZhiJ, ZhaoJ, GaoM, et al.. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases. Int J Clin Oncol, 2017, 295(1): 2164-2167

[7] Romero-RojasA, Cuervo-MartínezJ, Osorio-ArangoK, et al.. Histological variants and prognostic factors of papillary thyroid carcinoma at the Colombian Instituto Nacional de Cancerología, 2006–2012. Biomedica, 2015, 35(3): 429-436

[8] KimWG, KimTY, KimTH, et al.. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. Korean J Intern Med, 2014, 29(3): 325-333

[9] YuXM, SchneiderDF, LeversonG, et al.. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid, 2013, 23(10): 1263-1268

[10] KrayenbühlJC, HedingerC. Large-cell eosinophilic tumors of the thyroid gland. Schweiz Med Wochenschr (German), 1985, 115(15): 512-522

[11] NangueC, BronL, PortmannL, et al.. Mixed medullary-papillary carcinoma of the thyroid: report of a case and review of the literature. Head Neck, 2009, 31(7): 968-974

[12] LiuC, ZhaoQ, LiZ, et al.. Mixed subtype thyroid cancer: A surveillance, epidemiology, and end results database analysis. Oncotarget, 2017, 8(49): 86556-86565

[13] LiuZ, ZengW, ChenT, et al.. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis. Oncotarget, 2017, 8(4): 6222-6232

[14] GurkanE, GurbuzY, TarkunI, et al.. Mixed medullary-papillary carcinoma of the thyroid: report of two cases and review of the literature. Indian J Pathol Microbiol, 2014, 57(4): 598-602

[15] EloyC, Cameselle-TeijeiroJM, RousseauE, et al.. Small cell tumors of the thyroid gland: a review. Int J Surg Pathol, 2013, 22(3): 197-201

[16] CameronRG, SeemayerTA, WangNS, et al.. Small cell malignant tumors of the thyroid. A light and electron microscopic study. Hum Pathol, 1975, 6(6): 731-740

[17] RayfieldEJ, NishiyamaRH, SissonJC. Small cell tumors of the thyroid. A clinicopathologic study. Cancer, 1971, 28(4): 1023-1030

[18] LunaMA, MackayB, HillCS, et al.. The quarterly case: malignant small cell tumor of the thyroid. Ultrastruct Pathol, 1980, 1(2): 265-270

[19] CruzJ, EloyC, AragüésJM, et al.. Small-cell (basaloid) thyroid carcinoma: a neoplasm with a solid cell nest histogenesis?. Int J Surg Pathol, 2011, 19(5): 620-626

[20] PuenteS, VelascoA, GallelP, et al.. Metastatic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder. Endocr Pathol, 2008, 19(3): 190-196

[21] BeachDF, KlumpWJ, HaddadG, et al.. Extrapulmonary small cell: a novel case of small cell carcinoma of the thyroid gland. Med Oncol, 2012, 29(3): 1405-1408

[22] KumarM, GuptaP, ChaubeyA. The thyroid: an extremely rare primary site of neuroblastoma. Hum Pathol, 2006, 37(10): 1357-1360

[23] EloyC, VinagreJ, Cameselle-TeijeiroJ, et al.. Tumorin-tumor of the thyroid with basaloid differentiation: a lesion with a solid cell nest neoplastic component?. Int J Surg Pathol, 2011, 19(2): 276-280

[24] FaginJA, WellsSAJr. Biologic and clinical perspectives on thyroid cancer. N Engl J Med, 2016, 375(23): 1054-1067